Ceridian HCM Stock Price, News & Analysis (NYSE:CDAY)

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM Holding Inc (NYSE:CDAY) released its quarterly earnings data on Tuesday, July, 30th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.05. The business had revenue of $196.30 million for the quarter, compared to analyst estimates of $192.29 million. Ceridian HCM had a return on equity of 2.34% and a net margin of 4.19%. Ceridian HCM's revenue was up 9.7% compared to the same quarter last year. During the same period last year, the firm posted ($0.44) earnings per share. View Ceridian HCM's Earnings History.

Ceridian HCM is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Ceridian HCM.

Ceridian HCM updated its third quarter 2019 earnings guidance on Tuesday, July, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $195-197 million, compared to the consensus revenue estimate of $198.68 million.

12 brokerages have issued twelve-month price objectives for Ceridian HCM's shares. Their predictions range from $37.00 to $65.00. On average, they anticipate Ceridian HCM's stock price to reach $57.09 in the next twelve months. This suggests a possible upside of 27.6% from the stock's current price. View Analyst Price Targets for Ceridian HCM.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ceridian HCM.

News coverage about CDAY stock has been trending very negative this week, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ceridian HCM earned a daily sentiment score of -3.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Ceridian HCM.

Ceridian HCM saw a decline in short interest during the month of September. As of September 15th, there was short interest totalling 6,360,000 shares, a decline of 17.3% from the August 15th total of 7,690,000 shares. Based on an average trading volume of 967,700 shares, the short-interest ratio is currently 6.6 days. Approximately 7.3% of the company's shares are sold short. View Ceridian HCM's Current Options Chain.

Some companies that are related to Ceridian HCM include Veeva Systems (VEEV), Synopsys (SNPS), Cadence Design Systems (CDNS), ANSYS (ANSS), Splunk (SPLK), Check Point Software Technologies (CHKP), Twilio (TWLO), Tableau Software (DATA), Symantec (SYMC), Atlassian (TEAM), TAKE-TWO INTERACTIVE SOFTWARE (TTWO), Citrix Systems (CTXS), SS&C Technologies (SSNC), Paycom Software (PAYC) and Okta (OKTA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Alteryx (AYX), CTR COAST MLP &/COM (CEN), Ferrellgas Partners (FGP), Costco Wholesale (COST), The Ultimate Software Group (ULTI), Five Below (FIVE), NVIDIA (NVDA), Union Pacific (UNP) and Adobe (ADBE).

(CDAY) raised $420 million in an IPO on Thursday, April 26th 2018. The company issued 21,000,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities acted as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM's stock is owned by a number of of retail and institutional investors. Top institutional investors include Zeke Capital Advisors LLC (0.01%), Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%), Ingalls & Snyder LLC (0.00%) and Zurcher Kantonalbank Zurich Cantonalbank (0.00%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Paul D Elliott, Scott A Kitching and Thomas H Lee Advisors, Llc. View Institutional Ownership Trends for Ceridian HCM.

CDAY stock was acquired by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC, Zeke Capital Advisors LLC, Nelson Van Denburg & Campbell Wealth Management Group LLC and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for Ceridian HCM.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CDAY stock can currently be purchased for approximately $44.74.

Ceridian HCM has a market capitalization of $6.40 billion and generates $746.40 million in revenue each year. The company earns $-63,400,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Ceridian HCM employs 4,444 workers across the globe.View Additional Information About Ceridian HCM.

The official website for Ceridian HCM is http://www.ceridian.com/.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]